April 2001 Supplement Research Papers

• April 27

  • A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity of Escherichia coli O157:H7 infection in mice

    • 2001-04-27
    • Clinical Trial · n = 10
    • Medical Microbiology and Immunology 189(3)
    • • Q. Shu
      • H. Gill

    • PubMed: 11388612
    • DOI: 10.1007/s430-001-8021-9

    4 Insights on

    • Reduced Bacterial Translocation
    • Reduced Morbidity Rate
    • Enhanced Phagocytic Activity
    • Increased Intestinal Anti-E. coli IgA Antibody Responses

    • Low evidence
    • Highly Cited
    • Animal Study
• Undated – 3 supplement studies

  • Systemic Immunity-Enhancing Effects in Healthy Subjects Following Dietary Consumption of the Lactic Acid Bacterium Lactobacillus rhamnosus HN001

    • 2001-04
    • Clinical Trial · n = 52
    • Journal of the American College of Nutrition 20(2)
    • • Ying-H. Sheih
      • B. Chiang
      • L. Wang
      • Chuh-K. Liao
      • H. Gill

    • PubMed: 11349938
    • DOI: 10.1080/07315724.2001.10719027

    3 Insights on

    • Increased PMN Cell Phagocytic Capacity
    • Enhanced Natural Killer Cell Tumoricidal Activity
    • Improved Phagocytic Activity

    • High evidence
    • Highly Cited

  • Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk.

    • 2001-04
    • Observational
    • Nutrition 17(4)
    • • M. Kaneki
      • S. Hedges
      • T. Hosoi
      • S. Fujiwara
      • A. Lyons
      • S. Crean
      • Nobuhiko Ishida
      • Mamoru Nakagawa
      • Masahiro Takechi
      • Y. Sano
      • Y. Mizuno
      • S. Hoshino
      • M. Miyao
      • S. Inoue
      • Kiyomi Horiki
      • M. Shiraki
      • Yasuyoshi Ouchi
      • H. Orimo

    • PubMed: 11369171
    • DOI: 10.1016/S0899-9007(00)00554-2

    2 Insights on

    • Increased Circulating Vitamin K2 Levels
    • Reduced Hip Fracture Risk

    • Moderate evidence
    • Highly Cited

  • Saccharomyces boulardii Stimulates Intestinal Immunoglobulin A Immune Response to Clostridium difficileToxin A in Mice

    • 2001-04
    • Clinical Trial
    • Infection and Immunity 69(4)
    • • A. Qamar
      • Samer Aboudola
      • M. Warny
      • P. Michetti
      • C. Pothoulakis
      • J. Lamont
      • C. Kelly

    • PubMed: 11254650
    • DOI: 10.1128/IAI.69.4.2762-2765.2001

    2 Insights on

    • Increased Intestinal Immunoglobulin A Levels
    • Increased Anti-toxin A Levels

    • Low evidence
    • Highly Cited
    • Animal Study